MicroRNA hsa-miR-4674 in Hemolysis-Free Blood Plasma Is Associated with Distant Metastases of Prostatic Cancer
- 1 May 2016
- journal article
- research article
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 161 (1) , 112-115
Abstract
We analyzed microRNA profile in hemolysis-free blood plasma of patients with prostatic cancer. The metastatic form of prostatic cancer was found to be associated with increased levels of hsa-miR-22-3p, hsa-miR-663a, and hsa-miR-4674 in comparison with non-metastatic form. Common candidate target genes of these microRNA include JUNB, KMT2A, and XPO6.Keywords
This publication has 15 references indexed in Scilit:
- Analysis of Plasma microRNA Associated with HemolysisBulletin of Experimental Biology and Medicine, 2016
- Profile of microRNA in Blood Plasma of Healthy HumansBulletin of Experimental Biology and Medicine, 2016
- Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer TumorigenesisPLOS ONE, 2015
- Circulating microRNAsBiochemistry (Moscow), 2015
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate CancerNew England Journal of Medicine, 2015
- Rac1 Nucleocytoplasmic Shuttling Drives Nuclear Shape Changes and Tumor InvasionDevelopmental Cell, 2015
- Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasisJournal of Extracellular Vesicles, 2015
- miRNome of inflammatory breast cancerBMC Research Notes, 2014
- miR-663 Induces Castration-Resistant Prostate Cancer Transformation and Predicts Clinical RecurrenceJournal of Cellular Physiology, 2013
- DIANA-microT Web server upgrade supports Fly and Worm miRNA target prediction and bibliographic miRNA to disease associationNucleic Acids Research, 2011